Tregalizumab is an immunomodulator. It is also known as BT-061. Tregalizumab binds to domain 2 of CD4, and activates Regulatory T cells (Tregs). World...
3 KB (139 words) - 23:04, 10 July 2021
Talizumab Teclistamab Teplizumab Tislelizumab Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation:...
38 KB (4,316 words) - 10:24, 26 August 2024
HER2/neu Y breast cancer TRBS07 Ektomab 3funct GD2 ganglioside melanoma Tregalizumab mab humanized CD4 Tremelimumab Imjudo mab human CTLA-4 Y hepatocellular...
136 KB (4,020 words) - 06:13, 27 September 2024
trecadrine (INN) Trecator-Sc Trecondyv trecovirsen (INN) trefentanil (INN) tregalizumab (INN) trelagliptin (USAN) trelanserin (USAN) trelnarizine (INN) treloxinate...
12 KB (561 words) - 06:15, 21 September 2024
Talizumab Teclistamab Teplizumab Tislelizumab Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation:...
2 KB (87 words) - 01:28, 30 May 2023